Job Trends
Shares of Endo International are up more than 5% after the company announced positive earnings Thursday and also announced a new restructuring plan.
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
Looking for a job in regulatory? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
THE LATEST
J&J is balking at a plan to build a site in Britain due to concerns over the economy.
Qiagen’s investment will be an expansion of its current operations in that northern England city.
The move is in part related to Brexit, the UK’s exit from the European Union.
Eli Lilly continues to make investments in its diabetes business.
Fresenius Kabi will invest $100M in eastern North Carolina as it expands its current production facility and prepares to build a new onsite manufacturing center.
Less than one week after the FDA cleared Innovative Health Solutions’ NSS-2 Bridge, the company announced it will expand its payroll to include a number of new businesses.
When complete, the expansion is expected to double the size of Regeneron’s footprint in Greenburgh.
The opportunity to work at the leading edge of science and technology while working on solutions to some of the world’s most vexing problems is what attracts people to Verily.
Investors love to speculate on M&A, and one of the hottest topics of speculation recently has been whether someone will buy BMS.
Pfizer is planning to hire 200 new staffers and another 200 replacement workers in Michigan.